Consort Medical plc (LON:CSRT)‘s stock had its “hold” rating reissued by research analysts at Stifel Nicolaus in a report issued on Thursday. They presently have a GBX 1,100 ($13.92) price objective on the stock. Stifel Nicolaus’ target price suggests a potential upside of 7.00% from the company’s current price.

CSRT has been the topic of a number of other research reports. Shore Capital reaffirmed a “buy” rating on shares of Consort Medical plc in a report on Thursday. N+1 Singer reaffirmed a “buy” rating and issued a GBX 1,125 ($14.23) target price on shares of Consort Medical plc in a report on Thursday. Numis Securities Ltd assumed coverage on Consort Medical plc in a report on Tuesday, April 4th. They issued a “hold” rating and a GBX 1,084 ($13.71) target price on the stock. Finally, Investec reaffirmed a “buy” rating and issued a GBX 1,165 ($14.74) target price on shares of Consort Medical plc in a report on Thursday. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Consort Medical plc presently has an average rating of “Buy” and a consensus target price of GBX 1,153.17 ($14.59).

Analyst Recommendations for Consort Medical plc (LON:CSRT)

Consort Medical plc (CSRT) opened at 1011.03 on Thursday. The stock’s market capitalization is GBX 493.92 million. The stock’s 50 day moving average price is GBX 1,042.28 and its 200 day moving average price is GBX 1,027.90. Consort Medical plc has a 1-year low of GBX 940.00 and a 1-year high of GBX 1,180.00.

WARNING: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/06/15/consort-medical-plcs-csrt-hold-rating-reaffirmed-at-stifel-nicolaus.html.

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.